-
Je něco špatně v tomto záznamu ?
Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma
E. Křepela, P. Daňková, E. Moravčíková, A. Křepelová, J. Procházka, J. Čermák, J. Schützner, P. Zatloukal, K. Benková
Jazyk angličtina Země Řecko
Typ dokumentu práce podpořená grantem
NLK
Free Medical Journals
od 2006 do Před 1 rokem
- MeSH
- adaptorové proteiny signální transdukční biosyntéza MeSH
- dospělí MeSH
- ELISA MeSH
- exprese genu MeSH
- inhibitory apoptózy MeSH
- lidé středního věku MeSH
- lidé MeSH
- messenger RNA analýza MeSH
- nádory plic metabolismus MeSH
- nemalobuněčný karcinom plic metabolismus MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- proteiny asociované s mikrotubuly biosyntéza MeSH
- senioři MeSH
- stanovení celkové genové exprese MeSH
- western blotting MeSH
- X-vázaný inhibitor apoptózy biosyntéza MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
Members of the inhibitor of apoptosis protein (IAP) family, survivin and X-chromosome-linked IAP (XIAP), contribute to apoptosis resistance of cancer cells, and an increase in their expression may elevate the apoptotic threshold of malignant tumours during their growth and progression. In the present study, we investigated the expression status of survivin and its interactants hepatitis B X-interacting protein (HBXIP) and XIAP in non-small cell lung carcinoma (NSCLC) cell lines and NSCLC tumours and matched lungs from surgically treated patients in relation to their clinicopathological data. The expression of survivin, HBXIP and XIAP mRNAs was quantitated by real-time RT-PCR. The expression of survivin and XIAP proteins was analysed by Western blotting and ELISA. Survivin mRNA and protein levels were highly upregulated in NSCLC cells and tissues as compared to the lungs. In fact, the levels of survivin mRNA and protein in the tumours were more than 10-fold higher in 96 (64%) and 72 (82%) of the 150 and 88 examined NSCLC patients, respectively. The expression of survivin mRNA was higher in squamous cell lung carcinomas than in lung adenocarcinomas (LACs; P=0.003) and in less-differentiated tumours than in well-differentiated ones (P=0.007). The level of survivin protein was higher in stage IB and stage II+III tumours (P=0.049 and P=0.044), than in stage IA tumours. The BIRC5 promoter polymorphism at nucleotide -31 did not influence the expression of survivin mRNA and protein in NSCLC cells and tumours. HBXIP mRNA was abundantly expressed in NSCLC cell lines and NSCLC tumours and lungs, while its level was comparable in the tumours and lungs. The expression of XIAP mRNA in NSCLC cell lines and NSCLC tumours and lungs was not significantly different. However, the expression of XIAP protein was higher in NSCLC tumours, particularly in LACs, as compared to the lungs (P=0.017 and P=0.004). In conclusion, the overexpression of survivin in the majority of NSCLCs together with the abundant or upregulated expression of HBXIP and XIAP suggest that tumours are endowed with resistance against a variety of apoptosis-inducing conditions.
- 000
- 04119naa a2200517 a 4500
- 001
- bmc12008639
- 003
- CZ-PrNML
- 005
- 20121203114101.0
- 008
- 120316s2009 gr eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $d ABA008
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Křepela, Evžen $7 xx0083612 $u Laboratories of Molecular and Cell Biology, University Hospital Bulovka, Prague, Czech Republic. krepelae@fnb.cz
- 245 10
- $a Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma $c E. Křepela, P. Daňková, E. Moravčíková, A. Křepelová, J. Procházka, J. Čermák, J. Schützner, P. Zatloukal, K. Benková
- 520 9_
- $a Members of the inhibitor of apoptosis protein (IAP) family, survivin and X-chromosome-linked IAP (XIAP), contribute to apoptosis resistance of cancer cells, and an increase in their expression may elevate the apoptotic threshold of malignant tumours during their growth and progression. In the present study, we investigated the expression status of survivin and its interactants hepatitis B X-interacting protein (HBXIP) and XIAP in non-small cell lung carcinoma (NSCLC) cell lines and NSCLC tumours and matched lungs from surgically treated patients in relation to their clinicopathological data. The expression of survivin, HBXIP and XIAP mRNAs was quantitated by real-time RT-PCR. The expression of survivin and XIAP proteins was analysed by Western blotting and ELISA. Survivin mRNA and protein levels were highly upregulated in NSCLC cells and tissues as compared to the lungs. In fact, the levels of survivin mRNA and protein in the tumours were more than 10-fold higher in 96 (64%) and 72 (82%) of the 150 and 88 examined NSCLC patients, respectively. The expression of survivin mRNA was higher in squamous cell lung carcinomas than in lung adenocarcinomas (LACs; P=0.003) and in less-differentiated tumours than in well-differentiated ones (P=0.007). The level of survivin protein was higher in stage IB and stage II+III tumours (P=0.049 and P=0.044), than in stage IA tumours. The BIRC5 promoter polymorphism at nucleotide -31 did not influence the expression of survivin mRNA and protein in NSCLC cells and tumours. HBXIP mRNA was abundantly expressed in NSCLC cell lines and NSCLC tumours and lungs, while its level was comparable in the tumours and lungs. The expression of XIAP mRNA in NSCLC cell lines and NSCLC tumours and lungs was not significantly different. However, the expression of XIAP protein was higher in NSCLC tumours, particularly in LACs, as compared to the lungs (P=0.017 and P=0.004). In conclusion, the overexpression of survivin in the majority of NSCLCs together with the abundant or upregulated expression of HBXIP and XIAP suggest that tumours are endowed with resistance against a variety of apoptosis-inducing conditions.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a adaptorové proteiny signální transdukční $x biosyntéza $7 D048868
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a senioři $7 D000368
- 650 02
- $a western blotting $7 D015153
- 650 02
- $a nemalobuněčný karcinom plic $x metabolismus $7 D002289
- 650 02
- $a ELISA $7 D004797
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a exprese genu $7 D015870
- 650 02
- $a stanovení celkové genové exprese $7 D020869
- 650 02
- $a lidé $7 D006801
- 650 02
- $a inhibitory apoptózy $7 D051034
- 650 02
- $a nádory plic $x metabolismus $7 D008175
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a proteiny asociované s mikrotubuly $x biosyntéza $7 D008869
- 650 02
- $a lidé středního věku $7 D008875
- 650 02
- $a messenger RNA $x analýza $7 D012333
- 650 02
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 02
- $a X-vázaný inhibitor apoptózy $x biosyntéza $7 D051636
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Daňková, Petra
- 700 1_
- $a Moravčíková, Erika
- 700 1_
- $a Křepelová, Anna, $d 1955- $7 ja20020046544
- 700 1_
- $a Procházka, Jan
- 700 1_
- $a Čermák, Jan
- 700 1_
- $a Schützner, Jan, $d 1953- $7 mzk2005294945
- 700 1_
- $a Zatloukal, Petr, $d 1955-2012 $7 jn20000402715
- 700 1_
- $a Benková, Kamila, $d 1963- $7 xx0077689
- 773 0_
- $t International Journal of Oncology $p Int J Oncol $g Roč. 35, č. 6 (2009), s. 1449-1462 $w MED00002350 $x 0946-1965
- 773 0_
- $p Int J Oncol $g 35(6):1449-62, 2009 Dec
- 910 __
- $a ABA008 $b x $y 4
- 990 __
- $a 20120319124600 $b ABA008
- 991 __
- $a 20121203114132 $b ABA008
- 999 __
- $a ok $b bmc $g 901984 $s 765534
- BAS __
- $a 3
- BMC __
- $a 2009 $b 35 $c 6 $d 1449-1462 $m International journal of oncology $x MED00002350
- LZP __
- $a 2012-1Q10/